Acrolein-conjugated low-density lipoprotein induces macrophage foam cell formation

Atherosclerosis

Volumn 227, Issue 1, 2013, Pages 51-57

  Watanabe, Kenta ^a   Nakazato, Yuki ^a   Saiki, Ryotaro ^a   Igarashi, Kazuei ^a   Kitada, Mitsukazu ^b   Ishii, Itsuko ^a,b  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Acrolein; Atherosclerosis; Cholesterol; Lipoproteins; Macrophage

Indexed keywords

ACROLEIN; APOLIPOPROTEIN B; FAT DROPLET; LOW DENSITY LIPOPROTEIN; NEUTRALIZING ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR A;

ACUTE MONOCYTIC LEUKEMIA; AGAR GEL ELECTROPHORESIS; ARTICLE; BIOACCUMULATION; BIOTRANSFORMATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONFOCAL MICROSCOPY; CONJUGATE; CONTROLLED STUDY; FOAM CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; LIPID PEROXIDATION; LIPID TRANSPORT; LYSOSOME; MACROPHAGE; PRIORITY JOURNAL; PROTEIN MODIFICATION; WESTERN BLOTTING;

ACROLEIN; APOLIPOPROTEINS B; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; FOAM CELLS; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; SCAVENGER RECEPTORS, CLASS A;

EID: 84873466512     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.12.020     Document Type: Article

References (28)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999, 340:115-126.
2. Itabe H., Suzuki K., Tsukamoto Y., et al. Lysosomal accumulation of oxidized phosphatidylcholine-apolipoprotein B complex in macrophages: intracellular fate of oxidized low density lipoprotein. Biochim Biophys Acta 2000, 1487:233-245.
3. Anzinger J.J., Chang J., Xu Q., et al. Native low-density lipoprotein uptake by macrophage colony-stimulating factor-differentiated human macrophages is mediated by macropinocytosis and micropinocytosis. Arterioscler Thromb Vasc Biol 2010, 30:2022-2031.
4. Kunjathoor V.V., Febbraio M., Podrez E.A., et al. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem 2002, 277:49982-49988.
5. Steinbrecher U.P., Lougheed M. Scavenger receptor-independent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima. Arterioscler Thromb 1992, 12:608-625.
6. Jerome W.G., Cox B.E., Griffin E.E., Ullery J.C. Lysosomal cholesterol accumulation inhibits subsequent hydrolysis of lipoprotein cholesteryl ester. Microsc Microanal 2008, 14:138-149.
7. Sharmin S., Sakata K., Kashiwagi K., et al. Polyamine cytotoxicity in the presence of bovine serum amine oxidase. Biochem Biophys Res Commun 2001, 282:228-235.
8. Sakata K., Kashiwagi K., Sharmin S., et al. Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients. Biochem Biophys Res Commun 2003, 305:143-149.
9. Tomitori H., Usui T., Saeki N., et al. Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke. Stroke 2005, 36:2609-2613.
10. Waragai M., Yoshida M., Mizoi M., et al. Increased protein-conjugated acrolein and amyloid-β40/42 ratio in plasma of patients with mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 2012, 32:33-41.
11. Saiki R., Park H., Ishii I., et al. Brain infarction correlates more closely with acrolein than with reactive oxygen species. Biochem Biophys Res Commun 2011, 404:1044-1049.
12. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991, 11:81-128.
13. Bradley M.A., Markesbery W.R., Lovell M.A. Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radic Biol Med 2010, 48:1570-1576.
14. Dong J.Z., Moldoveanu S.C. Gas chromatography-mass spectrometry of carbonyl compounds in cigarette mainstream smoke after derivatization with 2,4-dinitrophenylhydrazine. J Chromatogr A 2004, 1027:25-35.
15. Uchida K., Kanematsu M., Sakai K., et al. Protein-bound acrolein: potential markers for oxidative stress. Proc Natl Acad Sci USA 1998, 95:4882-4887.
16. Obama T., Kato R., Masuda Y., Takahashi K., Aiuchi T., Itabe H. Analysis of modified apolipoprotein B-100 structures formed in oxidized low-density lipoprotein using LC-MS/MS. Proteomics 2007, 7:2132-2141.
17. Ghosh S., Zhao B., Bie J., Song J. Macrophage cholesteryl ester mobilization and atherosclerosis. Vascul Pharmacol 2010, 52:1-10.
18. Ishii I., Oka M., Katto N., Shirai K., Saito Y., Hirose S. Beta-VLDL-induced cholesterol ester deposition in macrophages may be regulated by neutral cholesterol esterase activity. Arterioscler Thromb 1992, 12:1139-1145.
19. Ishii I., Yanagimachi M., Shirai K., Saito Y., Hirose S. Impact of monocyte colony-stimulating factor upon beta-very low density lipoprotein (beta-VLDL) cholesterol metabolism in tetradecanoyl phorbol acetate-derived THP-1 cells. Biochim Biophys Acta 1994, 1212:278-284.
20. Ishii I., Kimuro T., Saito Y., Hirose S. Cholesterol metabolism in monocyte-derived macrophages from macrophage colony-stimulating factor administered rabbits. Biochim Biophys Acta 1995, 1254:51-55.
21. Furuhata A., Ishii T., Kumazawa S., Yamada T., Nakayama T., Uchida K. N(epsilon)-(3-methylpyridinium)lysine, a major antigenic adduct generated in acrolein-modified protein. J Biol Chem 2003, 278:48658-48665.
22. Cai J., Bhatnagar A., Pierce W.M. Protein modification by acrolein: formation and stability of cysteine adducts. Chem Res Toxicol 2009, 22:708-716.
23. Maeshima T., Honda K., Chikazawa M., et al. Quantitative analysis of acrolein-specific adducts generated during lipid peroxidation-modification of proteins in vitro: identification of N(τ)-(3-propanal)histidine as the major adduct. Chem Res Toxicol 2012, 25:1384-1392.
24. Lambert C., Li J., Jonscher K., et al. Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-kappaB1 DNA binding domain. J Biol Chem 2007, 282:19666-19675.
25. Jessup W., Mander E.L., Dean R.T. The intracellular storage and turnover of apolipoprotein B of oxidized LDL in macrophages. Biochim Biophys Acta 1992, 1126:167-177.
26. Yoshida M., Higashi K., Kobayashi E., et al. Correlation between images of silent brain infarction, carotid atherosclerosis and white matter hyperintensity, and plasma levels of acrolein, IL-6 and CRP. Atherosclerosis 2010, 211:475-479.
27. Yoshida M., Mizoi M., Saiki R., et al. Relationship between metabolic disorders and relative risk values of brain infarction estimated by protein-conjugated acrolein, IL-6 and CRP together with age. Clin Chim Acta 2011, 412:339-342.
28. Higashi K., Yoshida M., Igarashi A., et al. Intense correlation between protein-conjugated acrolein and primary Sjögren's syndrome. Clin Chim Acta 2010, 411:359-363.